The Osler Radiation Oncology 2024 Subscription-Based Review

Release Date: May 21, 2024

Estimated Time to Complete: 38 hours

The Osler Institute recorded our Live Virtual Webinar, April 2024 comprehensive Radiation Oncology Review Course, and brought it to you! These Video files are stored “in the cloud,” so you can stream them anywhere, anytime, as long as you have an internet connection. You can watch or listen to them on your phone, computer, or tablet. Additionally, each online review is a downloadable copy of the syllabus corresponding to the Video lectures, available for your use while viewing or as a standalone study or clinical practice guide.
This Subscription-Based Review provides senior trainees and practicing clinicians with a comprehensive update on clinical knowledge. It helps prepare them for their Radiation Oncology exams (the initial certification and MOC). Emphasis is on evidence-based medicine, board-relevant standards of care, and new concepts, treatments, and imaging approaches. The written exams emphasize anatomy, epidemiology, etiological agents, natural history, pathology, tumor markers, initial clinical evaluation, staging, routes of spread, selection of treatment modality and techniques, surgical and adjuvant chemotherapy treatments, follow-up treatment and assessment, patterns of failure, and normal tissue effects, including complications; all of these areas are addressed. The review also covers the basic principles of radiobiology and physics relevant to clinical practice.
Objectives
After this review, each participant should be able to perform the following tasks for all cancers of the eleven ABR-defined component areas:

Describe the anatomy, epidemiology/etiologic agents, and natural history Explain the pathology and use of tumor markers
Describe the initial clinical evaluation, staging, and routes of disease spread (local and distant)
Summarize potential treatment modalities, including optimum beam and radiation sources, volume and dose calculations, and fractionation.
Discuss follow-up treatment and evaluation, patterns of failure, and normal tissue effects.
Discuss multimodality therapies, including sequence, interactions, and specific agents.
Describe brachytherapy applications and issues for all disease sites Outline the use of palliative care for brain, hepatic, and skeletal lesions, plus various obstructive scenarios
Implement a basic program of ethics, patient safety, and quality assurance in clinical practice

The Osler Radiation Oncology 2024 Subscription‑Based Review is best for radiation oncology residents, fellows, and practicing oncologists preparing for the American Board of Radiology (ABR) certification or recertification exams, as well as clinicians seeking a structured, accredited update across the breadth of radiation oncology.
Who Should Attend

Radiation oncology residents and fellows preparing for initial ABR board certification.
Practicing radiation oncologists pursuing recertification or refreshing their knowledge base.
Medical physicists and dosimetrists who want a deeper understanding of clinical radiation oncology principles.
Advanced practice providers (NPs, PAs) working in oncology who want structured exposure to radiation oncology.
Academic faculty and educators who teach radiation oncology and want updated exam‑aligned content.

 
+ Topics:
Musaddiq Awan MDMusaddiq Awan MD
Head and Neck Cancer I – III
Ralph Vatner, MD, PhDRalph Vatner, MD, PhD
Pediatric Brain Tumors
Brain Stem Glioma
Medulloblastoma
Intracranial Germ Cell Tumors
Ependymoma
Pediatric Gliomas
Pediatric CNS Questions
Wilms Tumor
Neuroblastoma
Rhabdomyosarcoma
Ewing’s Sarcoma
Pediatric Solid Questions
Paras Khandhar, MD, FAAP
Statistics, Evidence-Based Medicine (EBM)
Patient Safety & Quality Improvement
S. Peter Wu, MD
S. Peter Wu, MD
Early Stage Breast Cancer
Locally Advanced Breast Cancer
Carcinoma-in-situ and Misc (DCIS)
Todd Swanson, MD, PhD†
CNS Overview
Primary CNS Malignancies
CNS Metastasis of the Brain
CNS Metastasis Spine
Benign Disorders of CNS
Palliative Care
†Course Planning Committee
Steven Lin, MD, Ph.D.
Early-stage NSCLC
Locally Advanced NSCLC
Small Cell Lung Cancer
Rare Mediastinal Tumors
Jillian R. Gunther, MD PhD
Hodgkin Lymphoma
Non-Hodgkin Lymphoma
Multiple Myeloma and Solitary Plasmacytoma
Allison Quick MDAllison Quick, MD
Endometrial Cancer
Cervical Cancer
Vulvar Cancer
Image Coming Soon 3Vatsal Patel, MD, MBA, DABR
Anal Cancer
Colon Cancer
Bile Duct Cancer
Esophageal Cancer
Rectal Cancer
Gastric Cancer
Colon Cancer
Liver Cancer
Pancreatic Ampullary Cancer
Shalin J Shah MDShalin Shah, MD
Bladder, Ureter, Penile Cancer
Germ Cell, Kidney, Renal Pelvis Cancer
Early and Intermediate-Risk Prostate Cancer
High Risk and Metastatic Prostate Cancer
Adjuvant/Salvage Prostate Cancer